Lifestyle Interventions to Reduce Diabetes Risk

Diabetes Mellitus, Type 2 Clinical Trial

Official title:

Interventions to Reduce Diabetic Risk in Japanese Americans

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00006162
• Other study ID #: fujimotow (completed)
• Secondary ID: 1R01DK048152
• Status: Completed
• Phase: N/A
• First received: August 8, 2000
• Last updated: March 1, 2010
• Start date: October 1994
• Est. completion date: April 1999

Study information

• Verified date: March 2010
• Source: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Federal Government
• Study type: Interventional

Clinical Trial Summary

Type 2 diabetes is more frequent in Japanese Americans than in Japan or the U.S. non-Hispanic white population. This appears to be due to the effects of ''westernization'' to bring out metabolic changes that lead to diabetes. This study will look at whether increased physical activity and dietary changes will reduce or prevent the metabolic changes that lead to type 2 diabetes in Japanese Americans who have impaired glucose tolerance, a condition intermediate between normal glucose tolerance and diabetes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 0
• Est. completion date: April 1999
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 40 Years and older

Eligibility

Inclusion Criteria:

• Japanese American

• Confirmed impaired glucose tolerance

• Able to fill out questionnaires

Exclusion Criteria:

• Significant exercise-restricting disease

• Poorly controlled hypertension

• Psychiatric disease or dementia

• Already on unusually restrictive diet

• Use of hypolipidemic drugs

• Use of tobacco

• Abnormal blood screening tests

• ECG evidence of ischemic heart disease at rest

• Abnormal maximal Bruce treadmill test

Study Design

Allocation: Randomized, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Diabetes Mellitus, Type 2
• Glucose Intolerance

Intervention

Behavioral:
• exercise and diet

Locations

Country	Name	City	State
United States	University of Washington	Seattle	Washington

Sponsors (1)

Lead Sponsor	Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States,